Rheb promotes cancer cell survival through p27Kip1-dependent activation of autophagy

Molecular Carcinogenesis

Volumn 55, Issue 2, 2016, Pages 220-229

  Campos, Tania ^a   Ziehe, Javiera ^a   Palma, Mario ^a   Escobar, David ^a   Tapia, Julio C ^b   Pincheira, Roxana ^a   Castro, Ariel F ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

MTORC1 independent; N terminal of p27; Rheb GTPase

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; RHEB PROTEIN; SMALL INTERFERING RNA; CDKN1B PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; NEUROPEPTIDE; RHEB PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOPHAGY; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER CELL LINE; CANCER RESISTANCE; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; WESTERN BLOTTING; BINDING SITE; CHEMISTRY; METABOLISM; NEOPLASM; PHYSIOLOGICAL STRESS; TUMOR CELL LINE;

AUTOPHAGY; BINDING SITES; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MONOMERIC GTP-BINDING PROTEINS; NEOPLASMS; NEUROPEPTIDES; STRESS, PHYSIOLOGICAL;

EID: 84955184800     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22272     Document Type: Article

References (43)

1. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: An evolving paradigm. Nat Rev Cancer 2013; 13:714-726.
2. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144:646-674.
3. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-734.
4. Amaravadi RK, Yu D, Lum JJ, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-336.
5. Chen N, Debnath J. Autophagy and tumorigenesis. FEBS Lett 2010; 584:1427-1435.
6. Mathew R, Karantza-Wadsworth V, White E. Role of autophagy in cancer. Nat Rev Cancer 2007; 7:961-967.
7. Barth S, Glick D, Macleod KF. Autophagy: Assays and artifacts. J Pathol 2010; 221:117-124.
8. Hippert MM, O'Toole PS, Thorburn A. Autophagy in cancer: good, bad, or both. Cancer Res 2006; 66:9349-9351.
9. Wong PM, Puente C, Ganley IG, Jiang X. The ULK1 complex: sensing nutrient signals for autophagy activation. Autophagy 2013; 9:124-137.
10. Alers S, Loffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks. Mol Cell Biol 2012; 32:2-11.
11. Liang J, Shao SH, Xu ZX, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9:218-224.
12. Larrea MD, Wander SA, Slingerland JM. P27 as Jekyll and Hyde: Regulation of cell cycle and cell motility. Cell Cycle 2009; 8:3455-3461.
13. Short JD, Dere R, Houston KD, et al. AMPK-mediated phosphorylation of murine p27 at T197 promotes binding of 14-3-3 proteins and increases p27 stability. Mol Carcinog 2010; 49:14-13.
14. Castro AF, Rebhun JF, Clark GJ, Quilliam LA. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 2003; 278:32493-32496.
15. Huang J, Manning BD. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008; 412:179-190.
16. Lu KH, Wu W, Dave B, et al. Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res 2008; 14:2543-2550.
17. Mavrakis KJ, Zhu H, Silva RL, et al. Tumorigenic activity and therapeutic inhibition of Rheb GTPase. Genes Dev 2008; 22:2178-2188.
18. Nardella C, Chen Z, Salmena L, et al. Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic events. Genes Dev 2008; 22:2172-2177.
19. Lacher MD, Pincheira R, Zhu Z, et al. Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: Implications for cell proliferation and tumorigenesis. Oncogene 2010; 29:6543-6556.
20. Lacher MD, Pincheira RJ, Castro AF. Consequences of interrupted Rheb-to-AMPK feedback signaling in tuberous sclerosis complex and cancer. Small GTPases 2011; 2:211-216.
21. Neuman NA, Henske EP. Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis. EMBO Mol Med 2011; 3:189-200.
22. Melser S, Chatelain EH, Lavie J, et al. Rheb regulates mitophagy induced by mitochondrial energetic status. Cell Metab 2013; 17:719-730.
23. Tapia JC, Bolanos-Garcia VM, Sayed M, Allende CC, Allende JE. Cell cycle regulatory protein p27KIP1 is a substrate and interacts with the protein kinase CK2. J Cell Biochem 2004; 91:865-879.
24. Giansanti V, Torriglia A, Scovassi AI. Conversation between apoptosis and autophagy: "Is it your turn or mine?" Apoptosis 2011; 16:321-333.
25. Gordy C, He YW. The crosstalk between autophagy and apoptosis: Where does this lead. Protein Cell 2012; 3:17-27.
26. Criollo A, Senovilla L, Authier H, et al. The IKK complex contributes to the induction of autophagy. EMBO J 2010; 29:619-631.
27. Garami A, Zwartkruis FJ, Nobukuni T, et al. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Molecular cell 2003; 11:1457-1466.
28. Mathew R, White E. Autophagy, stress, and cancer metabolism: what doesn't kill you makes you stronger. Cold Spring Harb Symp Quant Biol 2011; 76:389-396.
29. Saito K, Araki Y, Kontani K, Nishina H, Katada T. Novel role of the small GTPase Rheb: Its implication in endocytic pathway independent of the activation of mammalian target of rapamycin. J Biochem 2005; 137:423-430.
30. Sancak Y, Bar-Peled L, Zoncu R, et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 2010; 141:290-303.
31. Rubinsztein DC, Shpilka T, Elazar Z. Mechanisms of autophagosome biogenesis. Curr Biol 2012; 22:R29-R34.
32. Wu YC, Wu WK, Li Y, et al. Inhibition of macroautophagy by bafilomycin A1 lowers proliferation and induces apoptosis in colon cancer cells. Biochem Biophys Res Commun 2009; 382:451-456.
33. Kim JH, Kim HY, Lee YK, et al. Involvement of mitophagy in oncogenic K-Ras-induced transformation: Overcoming a cellular energy deficit from glucose deficiency. Autophagy 2011; 7:1187-1198.
34. Komata T, Kanzawa T, Takeuchi H, et al. Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells. Br J Cancer 2003; 88 1277-1280.
35. Sun X, Momen A, Wu J, et al. P27 protects metabolically-stressed cardiomyocytes from apoptosis by promoting autophagy. J Biol Chem 2014; 289(24):16924-16935.
36. Borriello A, Cucciolla V, Oliva A, Zappia V, Della Ragione. P27Kip1 metabolism: A fascinating labyrinth. Cell Cycle 2007; 6:1053-1061.
37. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253-267.
38. Lee J, Kim SS. The function of p27 KIP1 during tumor development. Exp Mol Med 2009; 41:765-771.
39. Short JD, Houston KD, Dere R, et al. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27. Cancer Res 2008; 68:6496-6506.
40. Furuya T, Kim M, Lipinski M, et al. Negative regulation of Vps34 by Cdk mediated phosphorylation. Mol Cell 2010; 38:500-511.
41. Kelsey I, Manning BD. MTORC1 status dictates tumor response to targeted therapeutics. Sci Signal 2013; 6:pe31.
42. Choo AY, Yoon SO, Kim SG, Roux PP, Blenis J. Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation. Proc Natl Acad Sci U S A 2008; 105:17414-17419.
43. Ducker GS, Atreya CE, Simko JP, et al. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene 2014; 33:1590-1600.